Search Results - Febe Smits

Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma by Gala Vega, Daniel Morillo, Christine Riedhammer, Febe Smits, Aishee Bag, Kelly Julian, Natalia Tovar Gomis, Carmen Montes Gaisan, Maria Aranzazu Bermudez, Mansi R. Shah, Ghulam Rehman Mohyuddin, Binod Dhakal, Leo Rasche, Carolina Schinke, Anita D'Souza, Aniko Szabo, Niels W. C. J. van de Donk, Rajshekhar Chakraborty, Meera Mohan

Get full text

Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first‐line therapy irrespective of frailty levels by Wassilis S. C. Bruins, Febe Smits, Carolien Duetz, Kazem Nasserinejad, Kazimierz Groen, Charlotte L. B. M. Korst, A. Vera deJonge, Rosa Rentenaar, Tamara Hageman, Meliha Cosovic, Merve Eken, Inoka Twickler, Paola M. Homan‐Weert, Christie P. M. Verkleij, Kristine Frerichs, Mark‐David Levin, Ellen van derSpek, Inger S. Nijhof, Roel vanKampen, Niels W. C. J. van deDonk, Sonja Zweegman, Tuna Mutis

Get full text

Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes by Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark‐David Levin, Josien C. Regelink, Gert‐Jan Timmers, Esther G. M. deWaal, Matthijs Westerman, Gerjo A. Velders, Koen deHeer, Rineke B. L. Leys, Roel J. W. vanKampen, Claudia A. M. Stege, Maarten R. Seefat, Inger S. Nijhof, Ellen van derSpek, Saskia K. Klein, Niels W. C. J. van deDonk, Paula F. Ypma, Sonja Zweegman

Get full text